FMS
Fresenius Medical Care AG
$
26.430
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
26.520
Open
26.390
VWAP
26.37
Vol
319.70K
Mkt Cap
7.75B
Low
26.190
Amount
8.43M
EV/EBITDA(TTM)
7.42
Total Shares
586.83M
EV
23.67B
EV/OCF(TTM)
9.78
P/S(TTM)
0.68
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
5.00B
+5%
0.466
+33.14%
5.00B
+5.07%
0.509
+24.27%
4.77B
-6.15%
0.634
+39.45%
Estimates Revision
The market is revising Downward the revenue expectations for Fresenius Medical Care AG (FMS) for FY2025, with the revenue forecasts being adjusted by -0.82% over the past three months. During the same period, the stock price has changed by 5.42%.
Revenue Estimates for FY2025
Revise Downward
-0.82%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+40.93%
In Past 3 Month
Stock Price
Go Up
+5.42%
In Past 3 Month
4 Analyst Rating
38.71% Upside
Wall Street analysts forecast FMS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FMS is 36.66 USD with a low forecast of 30.00 USD and a high forecast of 50.65 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
2 Hold
1 Sell
Hold
38.71% Upside
Current: 26.430
Low
30.00
Averages
36.66
High
50.65
38.71% Upside
Current: 26.430
Low
30.00
Averages
36.66
High
50.65
Deutsche Bank
Hold
maintain
2025-07-21
Reason
Deutsche Bank
Price Target
2025-07-21
maintain
Hold
Reason
Deutsche Bank raised the firm's price target on Fresenius Medical to EUR 50 from EUR 45 and keeps a Hold rating on the shares.
Goldman Sachs
downgrade
2025-07-01
Reason
Goldman Sachs
Price Target
2025-07-01
downgrade
Reason
Goldman Sachs analysts removed Fresenius Medical Care from the firm's European Conviction List as part of its monthly update.
Berenberg
NULL -> Buy
maintain
2025-06-23
Reason
Berenberg
Price Target
2025-06-23
maintain
NULL -> Buy
Reason
Berenberg raised the firm's price target on Fresenius Medical to EUR 60 from EUR 55 and keeps a Buy rating on the shares.
Citi
Neutral
maintain
2025-06-05
Reason
Citi
Price Target
2025-06-05
maintain
Neutral
Reason
Citi raised the firm's price target on Fresenius Medical to EUR 52.50 from EUR 46.50 and keeps a Neutral rating on the shares.
Morgan Stanley
Underweight
maintain
2025-05-15
Reason
Morgan Stanley
Price Target
2025-05-15
maintain
Underweight
Reason
Morgan Stanley raised the firm's price target on Fresenius Medical to EUR 43 from EUR 41 and keeps an Underweight rating on the shares.
Truist
Hold
maintain
$25 -> $30
2025-05-12
Reason
Truist
Price Target
$25 -> $30
2025-05-12
maintain
Hold
Reason
Truist raised the firm's price target on Fresenius Medical to $30 from $25 and keeps a Hold rating on the shares as part of a broader research note on Health Care Services. The firm is updating its models to reflect Q1 results and updated guidance on select names, the analyst tells investors in a research note.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Fresenius Medical Care AG (FMS.N) is 7.97, compared to its 5-year average forward P/E of 14.57. For a more detailed relative valuation and DCF analysis to assess Fresenius Medical Care AG 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Undervalued
5Y Average PE
14.57
Current PE
7.97
Overvalued PE
18.06
Undervalued PE
11.08
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Undervalued
5Y Average EV/EBITDA
7.79
Current EV/EBITDA
6.47
Overvalued EV/EBITDA
8.75
Undervalued EV/EBITDA
6.83
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
0.75
Current PS
0.67
Overvalued PS
0.98
Undervalued PS
0.51
Financials
Annual
Quarterly
FY2025Q1
YoY :
+0.04%
5.13B
Total Revenue
FY2025Q1
YoY :
+6.89%
443.18M
Operating Profit
FY2025Q1
YoY :
+55.17%
199.35M
Net Income after Tax
FY2025Q1
YoY :
+107.69%
0.54
EPS - Diluted
FY2025Q1
YoY :
-259.10%
11.39M
Free Cash Flow
FY2025Q1
YoY :
-2.38%
24.25
Gross Profit Margin - %
FY2025Q1
YoY :
-11.33%
8.69
FCF Margin - %
FY2025Q1
YoY :
+55.20%
3.88
Net Margin - %
FY2025Q1
YoY :
+17.19%
3.34
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
576.9K
Volume
2
6-9
Months
457.5K
Volume
2
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
150.0K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
FMS News & Events
Events Timeline
2025-07-03 (ET)
2025-07-03
08:07:10
Fresenius Medical extends HighVolumeHDF dialysis in Mexico
2025-06-17 (ET)
2025-06-17
07:14:46
Fresenius Medical launches its new FME Reignite strategy
2025-02-24 (ET)
2025-02-24
08:02:33
Fresenius Medical divesting select laboratory assets to Quest Diagnostics
Sign Up For More Events
Sign Up For More Events
News
5.0
07-16NASDAQ.COMEncompass Health Opens Rehabilitation Hospital in Florida
6.5
07-08NASDAQ.COMZacks.com featured highlights Fresenius Medical Care, Eldorado Gold, Hope Bancorp and Heritage Insurance
3.0
07-04NASDAQ.COMFMS vs. RXST: Which Stock Is the Better Value Option?
Sign Up For More News
People Also Watch
POOL
Pool Corp
324.900
USD
-0.44%
LINE
Lineage Inc
43.600
USD
+0.79%
CRDO
Credo Technology Group Holding Ltd
101.220
USD
+0.05%
RNR
Renaissancere Holdings Ltd
247.260
USD
+3.46%
ESLT
Elbit Systems Ltd
452.820
USD
+0.56%
ITCI
Intra-Cellular Therapies Inc
0
USD
-0.04%
VTRS
Viatris Inc
9.410
USD
+0.64%
TOL
Toll Brothers Inc
123.040
USD
+0.34%
XPEV
Xpeng Inc
18.970
USD
-0.84%
CNA
CNA Financial Corp
44.430
USD
+1.07%
FAQ
What is Fresenius Medical Care AG (FMS) stock price today?
The current price of FMS is 26.43 USD — it has decreased -1.23 % in the last trading day.
What is Fresenius Medical Care AG (FMS)'s business?
What is the price predicton of FMS Stock?
What is Fresenius Medical Care AG (FMS)'s revenue for the last quarter?
What is Fresenius Medical Care AG (FMS)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Fresenius Medical Care AG (FMS)'s fundamentals?
How many employees does Fresenius Medical Care AG (FMS). have?